ArticleWorld journal of urology2026
Robot-assisted artificial urinary sphincter implantation via a posterior vesicovaginal approach for female stress urinary incontinence due to intrinsic sphincter deficiency: mid-term outcomes from a prospective single-centre study.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate perioperative, functional, and safety outcomes of robot-assisted artificial urinary sphincter (AUS) implantation via a posterior vesicovaginal approach in women with stress urinary incontinence (SUI) secondary to intrinsic sphincter deficiency (ISD).
methodsA prospective single-centre study included consecutive women undergoing robot-assisted AUS implantation between September 2018 and March 2026. Functional outcomes were assessed using the 24-h pad test and International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF). Primary outcome was continence (complete or social). Secondary outcomes included perioperative results, complications (Clavien-Dindo), device-related events, and revision-free survival. Follow-up was conducted at regular intervals up to a mean of 38.1 months.
resultsTwenty-nine patients (mean age 57.1 year; 89.7% with prior SUI surgery) were included. Complete continence was achieved in 86.2% and social continence in 6.9%, with a failure rate of 6.9%. Significant improvements were observed in ICIQ-SF score (mean reduction 16.5 points; p < 0.001) and pad weight (mean reduction 670.5 g; p < 0.001). Mean operative time was 171.6 min and hospital stay 2.4 days. Intraoperative bladder injury occurred in 37.9% but was managed without sequelae. Early postoperative complications occurred in 13.8% (no reinterventions). Two patients (6.9%) required revision for mechanical failure; no infections or explantations were observed. Revision-free survival was 93.1%. Patient satisfaction was high (93.1% improved).
conclusionsRobot-assisted AUS implantation via a posterior vesicovaginal approach is a safe and effective option for women with SUI due to ISD, providing high continence rates, low postoperative complication and revision rates, and durable mid-term outcomes.
Indexed as
Identifiers
42487099What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.